Oppenheimer Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-19
| Closed | – | – | 1405 |
|
|
2020
Q1 | $0 | Sell |
19
-52
| -73% | – | ﹤0.01% | 1628 |
|
|
2019
Q4 | $2K | Hold |
71
| – | – | ﹤0.01% | 1574 |
|
|
2019
Q3 | $2K | Sell |
71
-10,296
| -99% | -$290K | ﹤0.01% | 1578 |
|
|
2019
Q2 | $343K | Sell |
10,367
-3,667
| -26% | -$121K | 0.01% | 921 |
|
|
2019
Q1 | $491K | Sell |
14,034
-4,519
| -24% | -$158K | 0.01% | 813 |
|
|
2018
Q4 | $616K | Buy |
18,553
+3,740
| +25% | +$124K | 0.02% | 695 |
|
|
2018
Q3 | $746K | Buy |
14,813
+1,251
| +9% | +$63K | 0.02% | 701 |
|
|
2018
Q2 | $812K | Sell |
13,562
-1,679
| -11% | -$101K | 0.02% | 654 |
|
|
2018
Q1 | $698K | Buy |
15,241
+282
| +2% | +$12.9K | 0.02% | 692 |
|
|
2017
Q4 | $598K | Hold |
14,959
| – | – | 0.02% | 742 |
|
|
2017
Q3 | $598K | Buy |
14,959
+4,738
| +46% | +$189K | 0.02% | 746 |
|
|
2017
Q2 | $441K | Sell |
10,221
-620
| -6% | -$26.8K | 0.01% | 815 |
|
|
2017
Q1 | $339K | Buy |
+10,841
| New | +$339K | 0.01% | 893 |
|